Webinar

Life Sciences MoForum 2022

Growth, Innovation, and Strategy

25 Jan - 27 Jan 2022 — 12:00 - 1:00 p.m. EST


The convergence of life sciences and technology continues to have a tremendous impact across the life sciences industry. Innovation is moving at a rapid pace, investment across the sector is at an all-time high, and companies are adopting new business models in response to the ongoing pandemic. 

Morrison & Foerster welcomed 100+ attendees for our virtual Life Sciences MoForum to discuss the business, legal, and regulatory trends that are driving innovation and growth in the life sciences today.

We hosted a series of three programs featuring leading life sciences innovators to discuss the key strategies shaping the industry today and what to expect in 2022. We concluded with a fireside chat with Shannon Klinger, chief legal officer of Moderna, who shared her unique perspective on the industry’s response to the pandemic and her outlook for the future.

Series Agenda

Tuesday, January 25, 2022
Digital Transformation in the Life Sciences

Moderated by: Brigid Bondoc, of counsel, FDA Regulatory and Compliance practice

Speakers include:

  • Melinda Decker, Digital Health Advisor and former Chief Commercial Officer, Mymee
  • Chris Bergstrom, President, Amalgam Rx
  • Laura Taraboanta, Sr. Manager, Head of Clinical Innovations, Click Therapeutics
  • Shaheen Lakhan, Chief Medical Officer, Click Therapeutics

Wednesday, January 26, 2022
The Future of Drug Discovery and Diagnostics

Moderated by: Matthew Karlyn, partner, Life Sciences Transactions & Licensing practice

Speakers include:

  • Scott Carter, Assistant General Counsel, BeiGene
  • Michelle Egger, Co-Founder & CEO, BIOMILQ
  • Daniel Oliver, Co-Founder & CEO, Rejuvenate Bio
  • William W. Li, M.D., President and Medical Director, The Angiogenesis Foundation

Thursday, January 27, 2022
Fireside Chat with Shannon Klinger, Chief Legal Officer, Moderna

Moderated by: Deanne Maynard, partner and co-chair Appellate and Supreme Court practice



Close
Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.